Difference between revisions of "QIBA Sustainability Implementation Committee (QSIC)"
Jump to navigation
Jump to search
m (→Mission) |
|||
(3 intermediate revisions by one other user not shown) | |||
Line 9: | Line 9: | ||
− | This is a closed group comprised of the following advisory committee members: | + | This is a ''closed'' group comprised of the following advisory committee members: |
*Gudrun Zahlmann, PhD (Chair) | *Gudrun Zahlmann, PhD (Chair) | ||
− | * | + | *Caroline Chung, MD, MSc, FRCPC, CIP |
− | |||
*Timothy J. Hall, PhD | *Timothy J. Hall, PhD | ||
+ | *Juan Carlos Ramirez-Giraldo, PhD | ||
*Annette Schmid, PhD | *Annette Schmid, PhD | ||
*Bram Stolk, PhD, MBA | *Bram Stolk, PhD, MBA | ||
*Daniel C. Sullivan, MD | *Daniel C. Sullivan, MD | ||
*Richard L. Wahl, MD, FACR | *Richard L. Wahl, MD, FACR | ||
+ | *Jeffrey T. Yap, PhD | ||
+ | |||
Please visit the QIBA Profile Conformance page for more information: http://qibawiki.rsna.org/index.php/QIBA_Profile_Conformance | Please visit the QIBA Profile Conformance page for more information: http://qibawiki.rsna.org/index.php/QIBA_Profile_Conformance | ||
Line 25: | Line 27: | ||
==Reference Materials== | ==Reference Materials== | ||
+ | * [https://docs.google.com/document/d/1YM0mreBRLNNQZicDatx1IE3Zi1NZeaojQJczrEIbvsk/edit?usp=sharing Biomarker Adoption Steps] |
Revision as of 19:45, 1 February 2022
- Chair: Gudrun Zahlmann, PhD
- RSNA Staff Support: Julie Lisiecki
Mission
The QSIC explores and develops opportunities to use QIBA Profiles in clinical care and / or clinical research to sustain QIBA activities.
This is a closed group comprised of the following advisory committee members:
- Gudrun Zahlmann, PhD (Chair)
- Caroline Chung, MD, MSc, FRCPC, CIP
- Timothy J. Hall, PhD
- Juan Carlos Ramirez-Giraldo, PhD
- Annette Schmid, PhD
- Bram Stolk, PhD, MBA
- Daniel C. Sullivan, MD
- Richard L. Wahl, MD, FACR
- Jeffrey T. Yap, PhD
Please visit the QIBA Profile Conformance page for more information: http://qibawiki.rsna.org/index.php/QIBA_Profile_Conformance